Healthcare -
Biotechnology - NASDAQ - US
$ 41.1
1.61 %
$ 2.66 B
Market Cap
-17.56
P/E
KYMR - SHORT-TERM INVESTMENTS
Short-term Investments KYMR - Kymera Therapeutics, Inc.
265 M
LAST VALUE
-18.05%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR